Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I D Horak

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Blood|September 15, 1993
The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemiaT A Waldmann, J D White, C K Goldman, et al.
Seminars in Oncology|May 13, 1998
Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomasM Adde, A Shad, D Venzon, et al.
Oncogene|April 1, 1989
Coordinate alteration of pp60c-src abundance and c-src RNA expression in human neuroblastoma variantsA Veillette, J O'Shaughnessy, I D Horak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimenI Magrath, M Adde, A Shad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristineM Weintraub, M A Adde, D J Venzon, et al.
Cancer Chemotherapy and Pharmacology|May 9, 2015
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neckJ-P Machiels, P Specenier, J Krauß, et al.
The Journal of Clinical Investigation|September 15, 1996
HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progressionI Stefanová, M W Saville, C Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancerS J Knox, M L Goris, M Tempero, et al.
Leukemia|August 17, 2011
Endogenous knockdown of survivin improves chemotherapeutic response in ALL modelsD J Morrison, L E Hogan, G Condos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancerJ Zujewski, I D Horak, C J Bol, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Blood|September 15, 1993
The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemiaT A Waldmann, J D White, C K Goldman, et al.
Seminars in Oncology|May 13, 1998
Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomasM Adde, A Shad, D Venzon, et al.
Oncogene|April 1, 1989
Coordinate alteration of pp60c-src abundance and c-src RNA expression in human neuroblastoma variantsA Veillette, J O'Shaughnessy, I D Horak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimenI Magrath, M Adde, A Shad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristineM Weintraub, M A Adde, D J Venzon, et al.
Cancer Chemotherapy and Pharmacology|May 9, 2015
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neckJ-P Machiels, P Specenier, J Krauß, et al.
The Journal of Clinical Investigation|September 15, 1996
HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progressionI Stefanová, M W Saville, C Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancerS J Knox, M L Goris, M Tempero, et al.
Leukemia|August 17, 2011
Endogenous knockdown of survivin improves chemotherapeutic response in ALL modelsD J Morrison, L E Hogan, G Condos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancerJ Zujewski, I D Horak, C J Bol, et al.
Pageof 3